Prelude Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Prelude Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,500	Closed	-$91K	–	2448
2018 Q3	$91K	Buy	+4,500	New	+$118K	0.01%	985
2018 Q2	–	Sell	-33,956	Closed	-$1.05M	–	2167
2018 Q1	$1.01M	Buy	+33,956	New	+$1.09M	0.07%	279
2017 Q2	–	Sell	-8,096	Closed	-$242K	–	2107
2017 Q1	$242K	Buy	+8,096	New	+$207K	0.02%	504
2016 Q4	–	Sell	-1,800	Closed	-$43K	–	2027
2016 Q3	$43K	Sell	1,800 -1,240	-41%	-$23.4K	﹤0.01%	1096
2016 Q2	$49K	Buy	+3,040	New	+$54.5K	0.01%	1021
2016 Q1	–	Sell	-300	Closed	-$8K	–	1823
2015 Q4	$8K	Buy	+300	New	+$8.18K	﹤0.01%	1286

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Prelude Capital Management's LJPC Position: Q4 2018 in Review

Prelude Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2018, closing a stake of 4,500 shares — an estimated $91K sold.

Prelude Capital Management first reported a position in LJPC in Q4 2015 and held it in 6 quarters. The position peaked at $1.01M in Q1 2018. 83 funds tracked by Wall St. Rank hold LJPC as of Q4 2018.

Prelude Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q4 2018 after selling out during the quarter.
Prelude Capital Management sold 4,500 La Jolla Pharmaceutical Company shares in Q4 2018, an estimated $91K.
Prelude Capital Management first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 6 quarters.
Prelude Capital Management's La Jolla Pharmaceutical Company position peaked at $1.01M in Q1 2018.
83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2018.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.